NFE2-related factor 2 (NRF2) is a transcription factor that integrates cellular stress signals and responds by directing various transcriptional programmes. NRF2 was a somewhat esoteric protein little ...

INrf2 tethering of the transcription factor Nrf2 in the cytosol prevents Nrf2 activation of antioxidant response element (ARE) mediated gene expression. This investigation was undertaken to determine ...

Lung cancer is the predominant cause of cancer related deaths. Within the main types of lung cancers, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), NSCLC accounts for ...

Backed by more than 30 peer-reviewed human clinical studies supporting endogenous antioxidant activity, cellular ...

Skeletal muscle mass and function becomes progressively compromised with aging, chronic disease, and physical inactivity. Oxidative stress plays an important role in loss of skeletal muscle mass and ...

Sapanisertib is a dual mTORC 1/2 inhibitor that targets a key survival mechanism in KEAP1/NRF2-mutated tumor cells. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Co. Ltd. has identified new acryloyl compounds acting as nuclear factor erythroid 2-related factor 2 (NFE2-related factor 2; NFE2L2; NRF2) inhibitors.

Prevalence and outcomes of lung abscess in hospitalized lung cancer patients: Insights from the Nationwide Inpatient Sample. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Vividion Therapeutics Inc. has disclosed VVD-065, a novel, first-in-class, allosteric molecular glue of the KEAP1-CUL3 E3-ligase complex, for the potential treatment of NRF2-activated cancers. NRF2 ...

SALT LAKE CITY, Nov. 29, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today ...